Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vermont Tech Scene.
Press releases published on September 4, 2025
Nusano Announces September Conference Schedule
GlobeNewswire
·
September 4, 2025
WEST VALLEY CITY, Utah, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Nusano, a leader in advanced isotope and energy technologies, today announced its September conference schedule. Nusano CEO Chris Lowe will participate in panel discussions and company leadership …
Pulmovant Receives Orphan Drug Designation in Japan for Mosliciguat for the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)
GlobeNewswire
·
September 4, 2025
Orphan drug designation from Japan’s Ministry of Health, Labour and Welfare provides key regulatory benefits, including priority review and extended market exclusivity for potential treatments targeting diseases for which there is no sufficient alternative …
Aquestive Therapeutics Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for Anaphylm™
GlobeNewswire
·
September 4, 2025
NDA remains on track for FDA PDUFA goal date of January 31, 2026 Commercial planning continues enabling rapid launch following approval WARREN, N.J., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “ …
Walden Biosciences Announces Key Initiatives to Advance Clinical Pipeline and Support Phase 2 Program for WAL0921 in Rare Kidney Diseases
GlobeNewswire
·
September 4, 2025
Engages Former FDA Director of Division of Cardiology and Nephrology, Norman Stockbridge, M.D., Ph.D., to Advise on Walden’s Clinical Pipeline in Rare Kidney Diseases Utilizes Rare Kidney Disease Patient Advocacy Group to Broaden Awareness and Outreach …
BPGbio Announces Completion of Enrollment for Phase 2b Trial of BPM31510 for Glioblastoma (GBM)
GlobeNewswire
·
September 4, 2025
Topline Phase 2b Clinical Data Expected in 1H 2026 Trial-in-Progress Presentations Scheduled for ESMO and SNO in Fall 2025 BPM31510 has Received Orphan Drug Designation from the U.S. FDA for the Treatment of GBM BOSTON, Sept. 04, 2025 (GLOBE NEWSWIRE) -- …
TappAlpha Expands ETF Lineup with the Innovation 100 Growth & Daily Income ETF (TDAQ)
GlobeNewswire
·
September 4, 2025
As TSPY surpasses $69 million in AUM, TappAlpha launches TDAQ to bring its daily income strategy to the NASDAQ-100. SEATTLE, Sept. 04, 2025 (GLOBE NEWSWIRE) -- TappAlpha, a fintech-powered ETF issuer focused on making advanced investment strategies …
BioXcel Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 4, 2025
NEW HAVEN, Conn., Sept. 04, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced that Vimal Mehta, Ph.D., CEO …
Skye’s CB1 Inhibitor, Nimacimab, Demonstrates Superior Weight Loss and Differentiated Mechanisms from Monlunabant, and Continues to Show Enhanced Combination with Tirzepatide with Durable Post-Treatment Weight Maintenance in DIO Model
GlobeNewswire
·
September 4, 2025
Skye shares new preclinical DIO data at virtual KOL event Nimacimab + tirzepatide demonstrates over 40% weight loss in multiple preclinical DIO studies Nimacimab demonstrates durable post-treatment weight loss compared to tirzepatide Nimacimab reduced …
Join XORTX for an Exclusive Live Investor Webinar and Q&A Session on September 10
GlobeNewswire
·
September 4, 2025
CALGARY, Alberta, Sept. 04, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and …
Aduro Clean Technologies to Participate in September Conferences and Initiates Public Relations Campaign
GlobeNewswire
·
September 4, 2025
LONDON, Ontario, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower-value feedstocks, like waste …
Agios Provides Update on U.S. PDUFA Goal Date for PYRUKYND® (mitapivat) in Thalassemia
GlobeNewswire
·
September 4, 2025
PDUFA goal date extended by three months from September 7, 2025, to December 7, 2025 CAMBRIDGE, Mass., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering …
GT Biopharma to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 4, 2025
The Company is available for one-on-one meetings at the H.C. Wainwright Conference September 8-10, 2025 in New York City Phase 1 trial evaluating GTBP-3650 for the treatment of relapsed or refractory (r/r) CD33 expressing hematologic malignancies continues …
Merakris Therapeutics Enrolls 30th Subject in Expanded Access Program of MTX-001; Highlights Clinical Progress at SAWC Fall 2025
GlobeNewswire
·
September 4, 2025
RESEARCH TRIANGLE PARK, N.C, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Merakris Therapeutics, a regenerative medicine company developing biologically derived therapeutics, announced the enrollment of the 30th subject in its Expanded Access Program (EAP) of MTX- …
Nano Banana AI - The Ultimate Tool to Edit Images Like a Pro
GlobeNewswire
·
September 4, 2025
LOS ANGELES, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Nano Banana AI, the breakthrough AI-powered image editor, is transforming how people edit and create visuals. Built with advanced spatial reasoning, multi-subject awareness, and lifelike rendering, Nano …
Combodo fête son quinzième anniversaire
GlobeNewswire
·
September 4, 2025
Combodo, éditeur Open Source de la solution iTop, revient sur la genèse de son projet lancé il y a désormais quinze ans Avant qu’il y ait Combodo, il y avait une idée Le 26 mai 2010, Combodo voyait officiellement le jour. Mais l’histoire, la vraie, avait …
Mobilehub : la gestion de parc IT qui muscle la performance et l’impact RSE
GlobeNewswire
·
September 4, 2025
Dans un monde où les équipements IT pullulent, se perdent, se cassent, ou se retrouvent dans un fond de tiroir, Mobilehub, logiciel SaaS made in France édité par bconnex, propose une gestion de parc simple, fluide et centrée sur l’utilisateur. Gérer un …
Ragnarok M: Classic Global Official Launching in North and South America, Europe, Middle East, Certain Regions of North Africa and Oceania on September 3, 2025
GlobeNewswire
·
September 4, 2025
Seoul, South Korea, Sept. 04, 2025 (GLOBE NEWSWIRE) -- GRAVITY Co., Ltd. (NasdaqGM: GRVY) (“Gravity” or “Company”), a developer and publisher of online and mobile games, announced that GRAVITY Interactive, Inc., Gravity's wholly-owned subsidiary, has …
ITM to Present at the Oppenheimer Annual Targeted Radiopharmaceutical Therapies in Oncology Summit
GlobeNewswire
·
September 4, 2025
Garching / Munich, Germany, September 4, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced its participation in the Oppenheimer Annual Targeted Radiopharmaceutical Therapies in Oncology Summit …
ESET Research discovers new Chinese threat group: GhostRedirector manipulates Google, poisons Windows servers with backdoors
GlobeNewswire
·
September 4, 2025
ESET Research observed at least 65 Windows servers compromised, based on an internet scan from June 2025. ESET believes that a previously unknown, China-aligned threat actor is likely behind these attacks. It has been named GhostRedirector by ESET …
Virtune announces that selected crypto ETPs are now available for automatic and commission-free monthly savings
GlobeNewswire
·
September 4, 2025
Stockholm, September 4, 2025 - Virtune today announces that selected crypto ETPs, including for Bitcoin, Ethereum, XRP, and Solana, are now available for monthly savings. This makes it easier than ever for investors to set up a long-term, automatic, and …